98 related articles for article (PubMed ID: 2459193)
1. Acid-induced conformational modification of the hemagglutinin molecule alters interaction of influenza virus with antigen-presenting cells.
Eisenlohr LC; Gerhard W; Hackett CJ
J Immunol; 1988 Sep; 141(6):1870-6. PubMed ID: 2459193
[TBL] [Abstract][Full Text] [Related]
2. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
Hackett CJ; Yewdell JW; Bennink JR; Wysocka M
J Immunol; 1991 May; 146(9):2944-51. PubMed ID: 1673146
[TBL] [Abstract][Full Text] [Related]
3. Individual class II-restricted antigenic determinants of the same protein exhibit distinct kinetics of appearance and persistence on antigen-presenting cells.
Eisenlohr LC; Gerhard W; Hackett CJ
J Immunol; 1988 Oct; 141(8):2581-4. PubMed ID: 2459219
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones.
Mills KH
Immunology; 1988 Nov; 65(3):365-71. PubMed ID: 2463222
[TBL] [Abstract][Full Text] [Related]
5. I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit.
Barnett BC; Burt DS; Graham CM; Warren AP; Skehel JJ; Thomas DB
J Immunol; 1989 Oct; 143(8):2663-9. PubMed ID: 2477451
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the murine TH response to influenza virus hemagglutinin: evidence for three major specificities.
Hurwitz JL; Herber-Katz E; Hackett CJ; Gerhard W
J Immunol; 1984 Dec; 133(6):3371-7. PubMed ID: 6208279
[TBL] [Abstract][Full Text] [Related]
7. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
Pinet V; Malnati MS; Long EO
J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
[TBL] [Abstract][Full Text] [Related]
8. Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes.
Eager KB; Hackett CJ; Gerhard WU; Bennink J; Eisenlohr LC; Yewdell J; Ricciardi RP
J Immunol; 1989 Oct; 143(7):2328-35. PubMed ID: 2789261
[TBL] [Abstract][Full Text] [Related]
9. Conformational-dependent recognition of influenza virus hemagglutinin by murine T helper clones.
Mills KH; Skehel JJ; Thomas DB
Eur J Immunol; 1986 Mar; 16(3):276-80. PubMed ID: 2420611
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
11. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
[TBL] [Abstract][Full Text] [Related]
12. Action of rimantadine on the structure of influenza A virus haemagglutinin.
Mikheeva AV; Melnikov AYa ; Anisimova E
Acta Virol; 1989 Mar; 33(2):131-6. PubMed ID: 2569808
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
14. Influenza virus-specific T cell-mediated cytotoxicity: integration of the virus antigen into the target cell membrane is essential for target cell formation.
Kurrle R; Wagner H; Röllinghoff M; Rott R
Eur J Immunol; 1979 Feb; 9(2):107-11. PubMed ID: 312203
[TBL] [Abstract][Full Text] [Related]
15. Autocatalytic activation of influenza hemagglutinin.
Lee JH; Goulian M; Boder ET
J Mol Biol; 2006 Dec; 364(3):275-82. PubMed ID: 17011576
[TBL] [Abstract][Full Text] [Related]
16. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin.
Wabuke-Bunoti MA; Taku A; Fan DP; Kent S; Webster RG
J Immunol; 1984 Oct; 133(4):2194-201. PubMed ID: 6206156
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibody response to influenza virus. II. Specificity of helper T cell recognizing hemagglutinin.
Anders EM; Katz JM; Jackson DC; White DO
J Immunol; 1981 Aug; 127(2):669-72. PubMed ID: 6166681
[TBL] [Abstract][Full Text] [Related]
18. Influenza virus M2 protein and haemagglutinin conformation changes during intracellular transport.
Ciampor F; Cmarko D; Cmarková J; Závodská E
Acta Virol; 1995 Jun; 39(3):171-81. PubMed ID: 8579000
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
20. Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains.
Katz JM; Laver WG; White DO; Anders EM
J Immunol; 1985 Jan; 134(1):616-22. PubMed ID: 3871116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
